These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20825269

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV, Joish VN, Camacho F, Drake CL.
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessing the relationship between compliance with antidepressant therapy and employer costs among employees in the United States.
    Birnbaum HG, Ben-Hamadi R, Kelley D, Hsieh M, Seal B, Kantor E, Cremieux PY, Greenberg PE.
    J Occup Environ Med; 2010 Feb; 52(2):115-24. PubMed ID: 20134337
    [Abstract] [Full Text] [Related]

  • 10. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E, Thacher JA, Craighead WE.
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA, Barghout V, Birnbaum HG, Thibeault CE, Ben-Hamadi R, Frech F, Ofman JJ.
    Arch Intern Med; 2003 Apr 28; 163(8):929-35. PubMed ID: 12719202
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness measures of major depressive disorder in pharmacoeconomic evaluations.
    Casciano R.
    Manag Care Interface; 2003 Apr 28; Suppl B():14-5. PubMed ID: 12647608
    [No Abstract] [Full Text] [Related]

  • 19. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
    Denee T, Ming T, Waller J, Bailey T, Rajkovic-Hooley O, Middleton-Dalby C, Le HH, Zhang Q, McCrone P, Taylor D.
    Curr Med Res Opin; 2021 Feb 28; 37(2):311-319. PubMed ID: 33253055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.